Amneal Pharmaceuticals, Inc. (AMRX)
12.21
-0.04
(-0.33%)
USD |
NASDAQ |
Dec 12, 16:00
12.20
-0.01
(-0.08%)
After-Hours: 20:00
Amneal Pharmaceuticals Research and Development Expense (Quarterly): 63.35M for Sept. 30, 2025
Research and Development Expense (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (Quarterly) Benchmarks
| AbbVie, Inc. | 2.319B |
| Johnson & Johnson | 3.693B |
| Amgen, Inc. | 1.90B |
| United Therapeutics Corp. | 127.50M |
| Xeris Biopharma Holdings, Inc. | 7.483M |